New insight into combatting drug-resistant prostate cancer

drug-resistant prostate cancer

New insight into combatting drug-resistant prostate cancer: New research from the University of Eastern Finland sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance could be prevented by limiting the activity of coregulator proteins. Glucocorticoids regulate vital biological processes by affecting gene encoding through […]

Read More… from New insight into combatting drug-resistant prostate cancer

Neuroendocrine prostate cancer treatment responsiveness restoration

Neuroendocrine prostate cancer

Neuroendocrine prostate cancer could be restored to a state that responds to treatment: In the new study researchers at the Ketola Lab discovered a potential new target for drug development in neuroendocrine prostate cancer was discovered. The protein, DPYSL5, is expressed especially in this cancer type and could therefore be a suitable target for drug […]

Read More… from Neuroendocrine prostate cancer treatment responsiveness restoration